MetaVia Presents Positive New Phase 2a Data on Vanoglipel (DA-1241) in Patients with Presumed MASH at the AASLD The Liver Meeting 2025
MetaVia Presents Positive New Phase 2a Data on Vanoglipel (DA-1241) in Patients with Presumed MASH at the AASLD The Liver Meeting 2025 MetaVia Presents Positive New Phase 2a Data on Vanoglipel...
PR Newswire·1mo ago
MetaVia Reports Third Quarter 2025 Financial Results and Provides Corporate Update
MetaVia Reports Third Quarter 2025 Financial Results and Provides Corporate Update MetaVia Reports Third Quarter 2025 Financial Results and Provides Corporate Update PR Newswire CAMBRIDGE, Mass...
PR Newswire·1mo ago
MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek 2025
MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek 2025 MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek 2025 PR Newswire CAMBRIDGE, Mass...
PR Newswire·1mo ago
MetaVia Announces Poster Presentation on Vanoglipel (DA-1241) at the AASLD Liver Meeting
MetaVia Announces Poster Presentation on Vanoglipel (DA-1241) at the AASLD Liver Meeting MetaVia Announces Poster Presentation on Vanoglipel (DA-1241) at the AASLD Liver Meeting PR Newswire...
PR Newswire·2mo ago
MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference
MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference PR Newswire CAMBRIDGE, Mass., Oct. 14, 2025...
PR Newswire·2mo ago
MetaVia to Present at Upcoming Investor and Industry Conferences
MetaVia to Present at Upcoming Investor and Industry Conferences MetaVia to Present at Upcoming Investor and Industry Conferences PR Newswire CAMBRIDGE, Mass., Aug. 26, 2025 CAMBRIDGE, Mass., Aug...